Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
HRT Women.com
Treatments7 min read

Progesterone for Menopause: Benefits, Side Effects and What to Expect

Why progesterone is prescribed with estrogen, micronized progesterone vs progestins, common progesterone side effects and when to call a clinician.

HTWritten by HRT Women Editorial TeamUpdated September 30, 2026

Key takeaways

  • If you have a uterus and take systemic estrogen, a progestogen such as progesterone is generally needed to protect the uterine lining.
  • Micronized progesterone (for example, Prometrium) is chemically identical to the body's own progesterone; synthetic progestins are related but different molecules.
  • Common side effects include drowsiness or dizziness, breast tenderness, bloating, mood changes and spotting - oral progesterone is usually taken at bedtime.
  • Prometrium capsules contain peanut oil and should not be used by people allergic to peanuts; serious symptoms need prompt medical attention.

Why progesterone is part of HRT

Estrogen is the part of HRT that relieves hot flashes and night sweats. But in a woman who still has a uterus, systemic estrogen taken on its own stimulates the uterine lining (endometrium) to grow, which raises the risk of endometrial hyperplasia and endometrial cancer. Adding a progestogen - the umbrella term for progesterone and synthetic progestins - counteracts that effect.

That is why women with a uterus are generally prescribed combined HRT, while women who have had a hysterectomy usually take estrogen alone. Progesterone's main job in menopausal HRT is endometrial protection, not symptom relief.

Micronized progesterone vs synthetic progestins

Micronized progesterone is chemically identical to the progesterone the ovaries make; "micronized" refers to the fine particle size that helps it be absorbed when swallowed. The best-known FDA-approved product is Prometrium, and generic versions are widely available. Synthetic progestins - such as medroxyprogesterone acetate or norethindrone - are related molecules with somewhat different effects, and they're used in some combined pills and patches and in the levonorgestrel IUD.

Many menopause clinicians favor micronized progesterone for its side-effect profile, but progestins remain valid options, and some women tolerate one better than the other. As with estrogen, "bioidentical" doesn't mean risk-free - see bioidentical hormones explained.

Top-Rated Providers

1
Our Top Pick
Winona logo
9.6
Exceptional

Physician-led online menopause care - estrogen, progesterone and vaginal estrogen prescribed without a video visit

  • Board-certified physicians
  • No video visit - online intake
  • Unlimited doctor messaging
  • Free delivery to your door

Free & Discreet Shipping

Visit Site
2
Gala logo
9.2
Excellent

Flat-fee menopause HRT from US-licensed clinicians, with ongoing check-ins and dose adjustments included

  • FDA-approved estradiol & progesterone
  • One monthly price, no insurance needed
  • Check-ins & dose adjustments included
  • Free shipping
Visit Site
3
Midi Health logo
8.9
Very Good

Insurance-billed video visits with menopause-trained clinicians, with prescriptions sent to your own pharmacy

  • In-network with most major insurance
  • Video visits with menopause specialists
  • Hormonal & non-hormonal care plans
  • Rx sent to your pharmacy of choice
Visit Site

Oral vs vaginal, cyclical vs continuous

Oral micronized progesterone is the standard, FDA-approved form for protecting the uterine lining in menopausal HRT. Some clinicians prescribe vaginal progesterone for women who get side effects from the oral form; in the US this is generally an off-label use for endometrial protection, and the evidence is more limited than for oral progesterone, so it's worth asking your clinician why it's being recommended.

Progesterone can be taken on two main schedules:

  • Cyclical (sequential) - taken for part of each month. The Prometrium label, for example, describes 200 mg at bedtime for 12 days of each 28-day cycle alongside daily estrogen. This usually brings a monthly withdrawal bleed and is common in perimenopause.
  • Continuous - a lower dose every day, usually aiming for no bleeding once things settle. It is more often used after menopause.

Your clinician will choose the product, dose and schedule based on your bleeding pattern and history - don't change them on your own. If you're still having periods, see HRT for perimenopause.

Common progesterone side effects

Many women take progesterone without much trouble, but side effects are common, especially in the first few months. The ones most often reported include:

  • Drowsiness or dizziness - which is why oral progesterone is usually taken at bedtime. Be cautious driving or operating machinery until you know how it affects you.
  • Breast tenderness.
  • Bloating and other stomach upset.
  • Mood changes - some women notice low mood, irritability or PMS-like symptoms, particularly on the progestogen days of a cyclical regimen.
  • Headache.
  • Spotting or bleeding - irregular bleeding is common early on, and cyclical regimens usually produce a regular monthly bleed.

If side effects are bothering you, tell your clinician. Options can include changing the timing, dose, schedule or type of progestogen - but those are decisions to make together.

Less common and serious warnings

A few important points from the prescribing information:

  • Peanut allergy - Prometrium capsules contain peanut oil and should not be used by anyone allergic to peanuts. Tell your clinician about any food allergies, and ask whether a generic you're given has the same ingredients.
  • Severe dizziness or drowsiness - during early treatment some women have had extreme dizziness or drowsiness, along with symptoms like blurred vision, slurred speech or difficulty walking. These need medical attention.
  • Contraindications - progesterone is generally not used in women with unexplained vaginal bleeding, known or suspected breast cancer, active or past blood clots or stroke, or significant liver disease, among others.

On February 12, 2026, the FDA approved updated labeling for Prometrium as one of the first six menopausal hormone therapy products to drop the boxed warning about cardiovascular disease, breast cancer and probable dementia. That reflects newer evidence about timing and age - it does not mean those risks disappeared. They remain in the prescribing information, and combined estrogen-plus-progestogen therapy is still associated with a small increase in breast-cancer risk with longer use. Read more in is HRT safe?

When to call a clinician

Seek emergency care for possible signs of a blood clot, stroke or heart attack: chest pain, sudden shortness of breath, pain or swelling in one leg, a sudden severe headache, sudden vision changes, or weakness, numbness or trouble speaking. Also get urgent help for signs of a serious allergic reaction.

Contact your clinician soon if you notice a new breast lump, yellowing of your skin or eyes, heavy or persistent bleeding (or any bleeding after you had stopped bleeding for 12 months), significant mood changes or depression, or side effects that don't settle after the first few months.

Getting progesterone through an online provider

If you take estrogen and have a uterus, any legitimate HRT provider should include a progestogen in your plan. Winona prescribes progesterone alongside its estradiol options, Gala offers oral or vaginal progesterone with FDA-approved estradiol, and Midi Health sends prescriptions to your own pharmacy. See how they compare in Winona vs Gala, Gala vs Midi Health, or our guide to what HRT is.

This article is general information, not medical advice. A licensed clinician should decide which progestogen, dose and schedule, if any, is right for you.

Ready to compare HRT providers?

See how top providers stack up on pricing, medical support, and treatment options.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.FDA Approves Labeling Changes to Menopausal Hormone Therapy Products - U.S. Food & Drug Administration - February 2026
  2. 2.FDA Requests Labeling Changes to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies - U.S. Food & Drug Administration - November 2025
  3. 3.The Women's Health Initiative Randomized Trials and Clinical Practice: A Review - Manson JE et al., JAMA - 2024;331(20):1748-1760
  4. 4.The 2022 hormone therapy position statement of The North American Menopause Society - Menopause (journal), The Menopause Society - 2022;29(7):767-794
  5. 5.The 2023 nonhormone therapy position statement of The North American Menopause Society - Menopause (journal), The Menopause Society - 2023
  6. 6.Menopause: identification and management (NG23, updated November 2024) - National Institute for Health and Care Excellence (NICE)
  7. 7.FDA Update on Estradiol Transdermal Patch Availability - U.S. Food & Drug Administration - 2026
  8. 8.Hormone Therapy for Menopause - patient FAQ - American College of Obstetricians and Gynecologists (ACOG)
  9. 9.Menopause - overview - National Institute on Aging (NIA), NIH